Evidence map›Paper›PMID 42527527›Full record

ArticleNature biotechnology2026

An AI-enabled structural atlas decodes kinase specificity across the human proteome.

David R Vanderwall, Edward L Huttlin, Julian Mintseris, Tomer M Yaron-Barir, Jared L Johnson, Kevin D Dong, Alex J Bott, Yuchen He, Christina B Schroeter, Geordon A Frere and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

David R VanderwallDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Edward L HuttlinDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1822-1173
Julian MintserisDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Tomer M Yaron-BarirDana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6574-7314
Jared L JohnsonDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1802-6527
Kevin D DongDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Alex J BottDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2273-8922
Yuchen HeDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Christina B SchroeterDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Geordon A FrereDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Mohamed UdumanCell Signaling Technology, Danvers, MA, USA.
Harin LeeCell Signaling Technology, Danvers, MA, USA.
Sean LandryCell Signaling Technology, Danvers, MA, USA.
Sean A BeausoleilCell Signaling Technology, Danvers, MA, USA.ORCID http://orcid.org/0000-0002-3356-4641
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4291-413X
Lewis C CantleyDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA. lewis_cantley@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-1298-7653
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA. steven_gygi@hms.harvard.edu.ORCID http://orcid.org/0000-0001-7626-0034

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
NIGMS NIH HHS T32 GM144273U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM67945U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM007753U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM144273
6 · The paper itself

Abstract

Of the 1.8 million serine/threonine/tyrosine residues in the human proteome, only 6% bear experimental validation of phosphorylation, and only 5% of these have been mapped to a kinase. Here we present KinoPlex, a computational framework that integrates predicted protein structures and kinase recognition motifs to assign phosphorylation potential and kinase specificity to all serine/threonine/tyrosine residues. Using ~20,000 AlphaFold models and positive-unlabeled transfer learning, we identified ~567,000 residues as structurally phospho-competent. We intersected these with kinase position-specific scoring matrices to quantify motif specificity, yielding ~250,000 high-confidence candidates with sequence recognition potential and optimal structural presentation. The structural atlas uncovered fundamental organizing principles guiding kinase substrate recognition and dynamics of phosphorylation, including a phenomenon we call sequence-structure selective coupling, whereby kinases achieve specificity through structural scarcity of their preferred motif (negative-selecting kinases) or promiscuity through its structural accessibility (positive-selecting kinases), rather than by motif discrimination alone. Deep phosphoproteomics in K562 cells validates KinoPlex predictions and kinase enrichment capacities.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.